The market is dominated by foreign suppliers, as imports account for 61.0% of total market size in 2023. Households drive market demand, with household spending representing 46.6% of total demand in 2023. Australia has the 11th largest market size for pharmaceuticals across the top 20 developed countries, with demand reaching USD26.7 billion in 2023. Johnson & Johnson Pacific Pty Ltd is the largest company in Australia, generating 15.6% of the industry’s total production value in 2023. The industry is concentrated, with the top five companies generating 66.6% of total production value in 2023. The total number of companies increases in 2023, to 688 units. The costs of the industry decrease by 1.8% in 2023, largely driven by declining labour costs. The industry’s profitability increases and stands at 26.7% of production value in 2023, the third highest across the top 20 developed countries. The industry’s exports share increases in 2023 to 17.5% of total production output. With production value of USD8.9 billion, Australia accounts for 91.2% of the Australasia total in 2023.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF.
This Euromonitor industrial report provides unique information on Pharmaceuticals in Australia: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in Australia: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
Pharmaceuticals and Medical Equipment is an aggregation of Pharmaceuticals, Medical and Surgical Equipment.
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!